Victory Capital Management Inc. trimmed its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 95.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,297 shares of the health services provider’s stock after selling 884,315 shares during the period. Victory Capital Management Inc. owned 0.07% of Maximus worth $2,859,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in MMS. Reinhart Partners LLC. raised its position in shares of Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after acquiring an additional 167,019 shares in the last quarter. Sio Capital Management LLC bought a new position in shares of Maximus in the 3rd quarter worth $14,453,000. Barclays PLC raised its position in shares of Maximus by 285.1% in the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock worth $15,927,000 after acquiring an additional 126,573 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Maximus in the 4th quarter worth $8,139,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 12.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after acquiring an additional 102,350 shares in the last quarter. 97.21% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts have recently commented on MMS shares. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.
Insider Buying and Selling at Maximus
In related news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bruce Caswell purchased 3,500 shares of Maximus stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average cost of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.60% of the company’s stock.
Maximus Stock Up 0.3 %
Shares of MMS stock opened at $67.06 on Monday. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The stock’s fifty day moving average price is $72.01 and its 200 day moving average price is $79.30. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 14.42 and a beta of 0.71.
Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.79%. Maximus’s payout ratio is presently 25.81%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- Are Penny Stocks a Good Fit for Your Portfolio?
- How to Build the Ultimate Everything ETF Portfolio
- What is the Nasdaq? Complete Overview with History
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is Forex and How Does it Work?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.